Emerging Global Leader Award (K43): PAR-24-296

Emerging Global Leader Award (K43): PAR-24-296

If you are a promising junior scientist in a low- or middle-income country and your institution wants you to become an independent investigator, the Emerging Global Leader Award (K43), PAR-24-296 is one of the most direct NIH-funded ways to convert career development into an independent research trajectory. This specific notice is explicitly designed to support LMIC researchers who can already show scientific potential and are ready for a protected path into leadership.

This is not a generic training stipend program. It is a structured NIH career-development award with explicit budget categories, duration expectations, and review cycles. The program is intended for institutions and candidate teams that are ready to build international mentorship across LMIC and U.S. partners, while still anchoring the research activity primarily in LMIC settings.

The official NIH page describes this as a K43 mechanism with a fixed career-development design, no independent clinical trials, and a competitive cycle-based application system with annual due dates.

At a glance

What this opportunity is (and is not)

A 3–5 year protected research-development route

The NOFO explicitly states the award aims to give research support and protected time to LMIC early-career scientists holding junior faculty positions. The protected time framing is central: the program is not only funding your project expenses but also building your ability to become an independent investigator over multiple years. In practice, that means a strong application should show how career-development activities and research are tied together, not treated separately.

Not a classic single-project travel grant

Some opportunities in the global health ecosystem look like project grants with occasional stipends. This one is stronger and narrower: it is a structured career pathway. Your application must show mentorship quality, institutional support, and a feasible personal development plan. The NOFO frames expectations for activities such as advanced methods, manuscript and grant writing, research administration, and scientific communication.

Not for applicants based at U.S. institutions

The NOFO is explicit that this notice is for non-U.S. institutions and LMIC scientists. U.S. citizens and candidates based at U.S. institutions are directed to other career-development routes. This matters because many otherwise strong candidates can waste time on an ineligible filing.

Why this matters for 2026/2027 applicants

The target-year requirement you gave is 2026 and 2027. This notice matches that window:

• The published key-date table includes cycles through December 3, 2026 and December 3, 2027.
• A new application due date in late 2026 is therefore directly in your range.
• The notice itself remains open as a recurring cycle opportunity and includes specific review and award dates for each cycle.

This is useful if you are planning long lead-time preparation while also wanting to hit an actual annual cycle. The notice explicitly shows that review and earliest start move in the annual pattern (review in March, council in May, earliest start July), which helps with institutional planning.

Who this award is built for

Primary candidate profile

The ideal applicant is a junior faculty member or equivalent research scientist in a LMIC academic/research institution. The NOFO emphasizes:

• Junior faculty or research scientist at an LMIC institution
• Minimum 1 year in this primary appointment at submission time
• Candidate-level focus on career growth in any health-related discipline aligned with local priorities
• Potential to become an independently funded principal investigator

The program also requires that the individual be citizen or permanent resident of an eligible country within NIH/Fogarty definitions and that the institution can support the administrative requirements for NIH submissions.

Institutional type

This is an institutional application route with an individual candidate at the center:

• The submitting entity is a foreign/non-U.S. academic or research institution in an eligible LMIC.
• The candidate should be the PD/PI (single PI model for this NOFO).
• Mentorship must be explicit with one primary LMIC mentor and one primary U.S. mentor.

What institutions should think about first

If your institution has limited international grant administration, this can be a bottleneck regardless of scientific quality. The NOFO requires registrations and identifiers (SAM/eRA/Grants.gov support) and these are frequent submission blockers. If your admin office cannot move the registrations early, treat the submission date as at risk.

Eligibility map from the official criteria

Use this as a pre-screen checklist before writing anything:

• Are candidate and institution LMIC-based? If no, you are not in scope.
• Clinical trial role: Are you proposing to lead an independent clinical trial? This award is not for that.
• Clinical trial feasibility: Clinical trial participation as part of a mentor-led experience is allowed, but independent trial lead is not.
• Effort commitment: Candidate commitment is explicit at minimum 75% effort (9 person-months).
• Career level: Applicant is a junior faculty/ research scientist level, with at least a master’s thesis degree.
• Regulatory fit: eRA Commons, SAM, and NIH systems must be set in advance.

The NOFO also sets boundary conditions around prior high-level PI status. For example, people already serving as PI on certain major NIH grants are ineligible; this is less relevant for some institutions than it is for the candidate career stage. Always verify these details because ineligibility here is usually discoverable late in review but before submission your application can still be rejected.

Funding structure and budget planning

The award budget is not a fixed flat grant amount but combines salary and program-related support:

• Salary support: NIH may contribute up to $100,000 per year toward the candidate salary for at least 75% effort.
• Research development support: NIH may contribute up to $40,000 per year.
• Direct support eligible for use includes non-degree tuition/fees linked to career development, research supplies/equipment/technical personnel, travel for research and mentoring activities, computational/statistical support, and communication.
• Indirect costs: Reimbursed at 8% of modified total direct costs.

How to treat this in your budget narrative

The budget must be realistic for a 3–5 year term. The NOFO gives minimum and maximum policy constraints but leaves institutional implementation details to the applicant team:

• Keep salary requests consistent with local institutional scales.
• Avoid inflating requested salary beyond what would be internally plausible.
• Keep project support tied to development activities rather than generic project padding.
• Use mentor travel and collaboration travel with explicit deliverables.

A frequent mistake is to submit a “research-only” budget and underestimate mentoring overhead. This award is judged partly on development logic; your budget should mirror your developmental pathway.

Key dates, timing, and decision architecture

The NOFO contains a full date table in Part 1. The key points relevant now are:

• Application due date shown: December 3, 2026 for one cycle (with prior and later annual cycles in table)
• Review/advisory timing: Review and advisory dates are in the following March/May sequence in the published cycle, with earliest start in July.
• Expiration: Posted as having expiration December 4, 2026 in table context.

These dates imply that even if you submit at the deadline, your administrative cleanup still needs to complete before review and startup.

Practical interpretation

For a 2026 applicant, this usually means you should treat 2026 as a preparatory year and not just a submission sprint:

1. Now (pre-submission): Build your mentorship model and institutional commitments.
2. By submission: Secure institutional letters and complete registrations.
3. Post-submission: Use peer review outcomes to strengthen the development plan if you stay in cycle scope for revisions.

The cycle nature means this is a route you can attempt with iterative learning if your first attempt is imperfect.

Application mechanics: what is required

The official path states applicants can submit through NIH systems via Grants.gov/ASSIST/eRA workflows. The practical implication:

• You must choose one compliant submission route and keep it complete.
• Missing registrations can nullify timing.
• Institutional officials (Signing Official, business office) need to be engaged early.

Minimum document logic (from NOFO sections)

At minimum, your package should clearly cover:

• Candidate career-development plan mapped to LMIC context
• Mentor agreements and mentorship structure
• Research project relevance to local health priorities
• Feasibility in the candidate institution and collaborating U.S. support
• Budget justification tied to explicit outputs and training milestones
• Evidence of institutional commitment, especially workload and protected time

The review logic behind the score

Review is not only about good science. For this program, evaluators also inspect:

• Suitability of developmental activities
• Strength of mentorship plan across LMIC and U.S. sides
• Feasibility and quality of the research plan in the resource setting
• Evidence that protected time is real and not just stated

A technically sound protocol with weak institutional support often underperforms. Treat protected time as a contractual condition, not a narrative line.

Strategic preparation roadmap for strong applications

1) Start with institutional feasibility, not just science

The NOFO assumes the institution is a co-owner of the program. Confirm:

• It can process SAM and eRA requirements on time.
• Internal HR can accommodate 75% effort protection in name and practice.
• Mentors can provide meaningful, documented support.

If these are uncertain, submit a pre-application discussion before investing into writing.

2) Build your development curriculum

Make your development plan specific:

• Technical capacity gaps (methods, analysis, writing)
• Mentoring milestones by quarter
• Outputs (papers, proposals, presentations)
• How this path leads to independent funding in 1–2 years after award

3) Build a mentoring architecture with clear roles

The NOFO expects both LMIC and U.S. mentors. Strong applications clearly identify:

• Primary LMIC mentor role and responsibilities
• Primary U.S. mentor role and responsibilities
• Coordination cadence and deliverables
• Backup mentoring pathways if one mentor becomes unavailable

4) Link research questions to country priorities

The NOFO is broad by discipline but bounded by local relevance. Avoid abstract “global” problems without a concrete local relevance chain.

5) Prepare budget as development evidence

Budget is your proof of execution plan. Keep entries aligned with:

• Salary at local institutional rates
• Clear use categories for research-development support
• Travel tied to collaboration, learning, and dissemination
• No prohibited salary stacking for mentors/secretarial staff in disallowed categories

Common mistakes and quick corrections

Mistake: Treating clinical-trial language as a side detail

The most damaging confusion is proposing leading trial roles under this “no independent clinical trial” award type. This can trigger eligibility or scientific issues before review. If the project requires lead trial responsibility, use the companion notice (PAR-24-295).

Mistake: Weak eligibility check

Some applications fail because of citizenship/appointment mismatch, prior PI history interpretation, or institutional ineligibility questions. Build a one-page eligibility checklist before registration.

Mistake: Assuming clinical collaboration removes all constraints

Mentored clinical exposure is allowed, but independent trial lead is not. Keep this distinction in protocol language and timeline.

Mistake: Underestimating administrative setup

The NOFO is clear that registration delays are not accepted as reason for late submission. Build registrations as a critical path item, not a pre-submit box.

Mistake: Vague mentorship and no protected time enforcement

If the LOI/application suggests the candidate is “expected” to have time but does not demonstrate practical release from other duties, the review may view the protected-time claim as weak.

Frequently asked questions

Is this a fellowship for students?

No. It is a career-development award for junior faculty/research scientists in LMIC institutions.

Is this tied to one disease area?

No. It is broad across health-related disciplines and open to multiple institute priorities, but country-relevant.

Can the same organization submit multiple applications?

Yes, if each comes from a different candidate and is scientifically distinct.

What if my institution is in an upper-middle-income country?

Country eligibility is constrained by NIH/Fogarty notices and exceptions. The NOFO references a country eligibility notice for detailed constraints, including upper-middle-income G20 interpretation. Verify current status before committing.

Can I submit from a U.S. institution through a partnership?

No. U.S.-based applicants are not eligible under this NOFO.

What makes a winning application here

At a high level, strong submissions show three things together:

1. Development logic is explicit. They are not just asking for money; they show how the candidate becomes independent.
2. Mentorship is operational. It is not just names on paper but an operational structure.
3. Research priorities are local and deliverable-driven. The project addresses clearly defined LMIC health priorities and maps to outputs.

If you can show this in one coherent storyline, the review can evaluate not just scientific potential but growth trajectory.

Official links and what to monitor next

• Official NOFO page: https://grants.nih.gov/grants/guide/pa-files/PAR-24-296.html
• Companion (clinical-trial-allowed pathway): https://grants.nih.gov/grants/guide/pa-files/PAR-24-295.html
• Fogarty opportunities landing page (for context and related notices): https://www.fic.nih.gov/Funding/Pages/Fogarty-Funding-Opps.aspx
• NIH How to Apply guidance (for instructions referenced in the NOFO): https://grants.nih.gov/grants/how-to-apply.html

Given the date and eligibility constraints, the immediate action is to validate institutional registrations, assemble mentor letters early, and start drafting development milestones around a clear, local-impact research trajectory.